Companies/US/ELOX

ELOXX PHARMACEUTICALS, INC.

Last · NASDAQ$12.21-0.49 (-3.86%)close · yahoo · 15h ago
Vol 12.5K ≈ 152.6K
Market cap$49.29M4.0M sh
P/E · TTM3.5fwd -17.2 · eps 3.46
Beta-171332.88vs S&P 500
Div yield0.00%annual · TTM
52w range
$8.20$23.40
Volume12.5Ksession

Issuer

Legal nameELOXX PHARMACEUTICALS, INC.
HQUnited States (US)
ListingUS ELOX
ISINUS29014R3012
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001035354
CIK0001035354
LinkedIn
Employees10
AddressEloxx Pharmaceuticals, Inc. 10 Court Street 02476, Arlington
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-17

From latest 10-K · 2026-03-17

  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Runway Low
  • Current Ratio Low

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -49.4%
  • Cash Runway Low — Cash runway ~0.8 years
  • Current Ratio Low — Current ratio 0.31

Documents

FormReporting forFiledFlags
2026-06-302026-08-11 2
2026-06-102026-06-170
2026-06-102026-06-100